BioSpace News Archive

Press Releases

Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward

December 11, 2024
·
7 min read
Press Releases

Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis

December 11, 2024
·
5 min read
Press Releases

Lilly’s Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer

December 11, 2024
·
26 min read
Press Releases

Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody

December 11, 2024
·
3 min read
Press Releases

Trinity Life Sciences Appoints Jonathan Jenkins From McKinsey’s QuantumBlack to Head up Its Digital & AI Initiatives

December 11, 2024
·
2 min read
Press Releases

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

December 11, 2024
·
4 min read
Press Releases

Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer

December 11, 2024
·
3 min read
Press Releases

Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease

December 11, 2024
·
4 min read
Press Releases

Negev Labs Emerges from Stealth with Announcement of Alexander Shulgin Research Institute Licensing Agreement, Acquisition of Beckley Psytech Development Program and R&D Collaboration with Hadassah Brain Labs Center for Psychedelic Research

December 11, 2024
·
6 min read
Press Releases

SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services

December 11, 2024
·
2 min read